B-cell depletion therapy for multiple sclerosis

by Yusei Miyazaki, Masaaki Niino
Published 2021-07-01

Beneficial effects of fingolimod in MS patients with high serum Sema4A levels.

by Toru Koda, Akiko Namba, Yuji Nakatsuji, Masaaki Niino, Yusei Miyazaki, Tomoyuki Sugimoto, Makoto Kinoshita, Kazushiro Takata, Kazuya Yamashita, Mikito Shimizu, Toshiyuki Fukazawa, Atsushi Kumanogoh, Hideki Mochizuki, Tatsusada Okuno
Published 2018-01-01

A novel microRNA-132-sirtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis [corrected].

by Yusei Miyazaki, Rui Li, Ayman Rezk, Hétoum Misirliyan, Craig Moore, Nasr Farooqi, Mayra Solis, Lorna Galleguillos Goiry, Omar de Faria Junior, Van Duc Dang, David Colman, Ajit Singh Dhaunchak, Jack Antel, Jennifer Gommerman, Alexandre Prat, Simon Fillatreau, Amit Bar-Or, CIHR/MSSC New Emerging Team Grant in Clinical Autoimmunity, MSSRF Canadian B cells in MS Team
Published 2014-01-01